Qingcheng New Drug-B (02396.HK): Jia Lijia Appointed as Chief Executive Officer of the Company

Zhitong Finance APP News, Qingcheng New Drug-B (02396.HK) announced that Ms. Jia Lijia, Chairman of the Board and Executive Director, has been appointed as the Chief Executive Officer (CEO) of the Company, effective from October 20, 2026. Her term as CEO will end on the date of expiration of the term of the first Board of Directors.